Update Breast Cancer 2018 (Part 2) - Advanced Breast Cancer, Quality of Life and Prevention

Related Experiment Video

Updated: Feb 12, 2026

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model
09:29

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

Published on: March 20, 2020

19.0K

Andreas Schneeweiss1,2, Michael P Lux3, Wolfgang Janni4

  • 1National Center for Tumor Diseases, Division Gynecologic Oncology, University Hospital Heidelberg, Heidelberg, Germany.

Geburtshilfe Und Frauenheilkunde
|March 27, 2018
PubMed

Insights

New therapies and supportive care are improving metastatic breast cancer treatment. Advances include targeted treatments for specific subgroups, like PARP inhibitors for BRCA mutations, and better management of side effects, enhancing patient prognosis and compliance.

Area of Science:

  • Oncology
  • Medical Research

Background:

  • Metastatic breast cancer treatment is complex, with numerous new therapies requiring evaluation.
  • Therapies are increasingly tailored to specific clinical, molecular, and histological subgroups.
  • Supportive care is advancing, improving management of side effects like alopecia and nausea.

Purpose of the Study:

  • To provide an overview of recent clinical trials in metastatic breast cancer.
  • To discuss how new findings may influence routine clinical practice.
  • To present current perspectives on breast cancer prevention.

Main Methods:

  • Review of recent clinical trials and therapeutic developments.
  • Analysis of targeted therapies for specific patient subgroups (e.g., PARP inhibitors for BRCA mutations).
  • Evaluation of advancements in supportive care and digital patient management tools.

Main Results:

  • Emerging therapies offer personalized treatment options for diverse breast cancer subtypes.
  • Improved supportive care enhances patient compliance and prognosis by managing treatment side effects.
  • Digital tools show potential for optimizing patient management systems.

Conclusions:

  • The landscape of metastatic breast cancer treatment is evolving with targeted therapies and enhanced supportive care.
  • Personalized treatment strategies and effective side effect management are crucial for improving patient outcomes.
  • Continued research and integration of digital tools are essential for advancing breast cancer care and prevention.
Keywords:
CDK4/6PD1/PDL1breast cancermetastasispreventionrisktreatmenttrials

More Related Videos

Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer07:45

Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer

Published on: May 18, 2020

7.1K
Modeling Breast Cancer in Human Breast Tissue using a Microphysiological System10:51

Modeling Breast Cancer in Human Breast Tissue using a Microphysiological System

Published on: April 23, 2021

4.7K

Related Concept Videos

Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
8.2K
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
54.5K
What is Cancer?02:12

What is Cancer?

Cells and tissues must meticulously coordinate their activities for the normal functioning of the human body. Therefore, they exhibit socially responsible behavior - resting, growing, dividing, differentiating, or dying - for the organism’s benefit. Cancer arises when cells divide uncontrollably and invade other tissues or organs.
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
14.5K
Half-life of a Reaction02:42

Half-life of a Reaction

The half-life of a reaction (t1/2) is the time required for one-half of a given amount of reactant to be consumed. In each succeeding half-life, half of the remaining concentration of the reactant is consumed. For example, during the decomposition of hydrogen peroxide, during the first half-life (from 0.00 hours to 6.00 hours), the concentration of H2O2 decreases from 1.000 M to 0.500 M. During the second half-life (from 6.00 hours to 12.00 hours), the concentration decreases from 0.500 M to...
39.4K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.2K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.1K